Does the media prefer BRKR or MTD?

In the previous week, Bruker had 6 more articles in the media than Mettler-Toledo International. MarketBeat recorded 8 mentions for Bruker and 2 mentions for Mettler-Toledo International. Bruker's average media sentiment score of 1.46 beat Mettler-Toledo International's score of 0.00 indicating that Bruker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bruker 8 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor MTD or RGEN?

In the previous week, Mettler-Toledo International had 1 more articles in the media than Repligen. MarketBeat recorded 2 mentions for Mettler-Toledo International and 1 mentions for Repligen. Repligen's average media sentiment score of 1.06 beat Mettler-Toledo International's score of 0.00 indicating that Repligen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Repligen 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to MTD or TECH?

In the previous week, Bio-Techne had 8 more articles in the media than Mettler-Toledo International. MarketBeat recorded 10 mentions for Bio-Techne and 2 mentions for Mettler-Toledo International. Bio-Techne's average media sentiment score of 0.72 beat Mettler-Toledo International's score of 0.00 indicating that Bio-Techne is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bio-Techne 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MTD or A?

In the previous week, Agilent Technologies had 12 more articles in the media than Mettler-Toledo International. MarketBeat recorded 14 mentions for Agilent Technologies and 2 mentions for Mettler-Toledo International. Agilent Technologies' average media sentiment score of 1.15 beat Mettler-Toledo International's score of 0.00 indicating that Agilent Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Agilent Technologies 10 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to MTD or BIO?

In the previous week, Mettler-Toledo International had 1 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 2 mentions for Mettler-Toledo International and 1 mentions for Bio-Rad Laboratories. Mettler-Toledo International's average media sentiment score of 0.00 equaled Bio-Rad Laboratories'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bio-Rad Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Mettler-Toledo International (MTD) Competitors

$1,145.08 +15.55 (+1.38%)

Closing price 03:59 PM Eastern

Extended Trading

$1,144.51 -0.57 (-0.05%)

As of 04:54 PM Eastern

Compare

MTD vs. BRKR, RGEN, TECH, A, and BIO

Should you buy Mettler-Toledo International stock or one of its competitors? MarketBeat compares Mettler-Toledo International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Mettler-Toledo International include Bruker (BRKR), Repligen (RGEN), Bio-Techne (TECH), Agilent Technologies (A), and Bio-Rad Laboratories (BIO).

How does Mettler-Toledo International compare to Bruker?

Bruker (NASDAQ:BRKR) and Mettler-Toledo International (NYSE:MTD) are both life sciences tools & services companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

Bruker currently has a consensus price target of $51.31, indicating a potential downside of 10.35%. Mettler-Toledo International has a consensus price target of $1,408.55, indicating a potential upside of 23.01%. Given Mettler-Toledo International's stronger consensus rating and higher probable upside, analysts clearly believe Mettler-Toledo International is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bruker	2 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.40
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

Mettler-Toledo International has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bruker	$3.44B	2.54	-$8.60M	-$0.24	N/A
Mettler-Toledo International	$4.09B	5.66	$869.19M	$42.64	26.85

79.5% of Bruker shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 27.2% of Bruker shares are owned by company insiders. Comparatively, 0.7% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Mettler-Toledo International has a net margin of 21.40% compared to Bruker's net margin of -0.65%. Bruker's return on equity of 11.60% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bruker	-0.65%	11.60%	4.25%
Mettler-Toledo International	21.40%	-622.80%	24.97%

In the previous week, Bruker had 6 more articles in the media than Mettler-Toledo International. MarketBeat recorded 8 mentions for Bruker and 2 mentions for Mettler-Toledo International. Bruker's average media sentiment score of 1.46 beat Mettler-Toledo International's score of 0.00 indicating that Bruker is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bruker	8 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Bruker has a beta of 1.31, meaning that its stock price is 31% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market.

Summary

Mettler-Toledo International beats Bruker on 10 of the 16 factors compared between the two stocks.

How does Mettler-Toledo International compare to Repligen?

Mettler-Toledo International (NYSE:MTD) and Repligen (NASDAQ:RGEN) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Mettler-Toledo International has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, Repligen has a beta of 1.09, indicating that its stock price is 9% more volatile than the broader market.

Mettler-Toledo International currently has a consensus target price of $1,408.55, indicating a potential upside of 23.01%. Repligen has a consensus target price of $164.64, indicating a potential upside of 24.71%. Given Repligen's stronger consensus rating and higher possible upside, analysts clearly believe Repligen is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46
Repligen	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.88

95.1% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 97.6% of Repligen shares are owned by institutional investors. 0.7% of Mettler-Toledo International shares are owned by company insiders. Comparatively, 0.6% of Repligen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Mettler-Toledo International had 1 more articles in the media than Repligen. MarketBeat recorded 2 mentions for Mettler-Toledo International and 1 mentions for Repligen. Repligen's average media sentiment score of 1.06 beat Mettler-Toledo International's score of 0.00 indicating that Repligen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mettler-Toledo International	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Repligen	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mettler-Toledo International has higher revenue and earnings than Repligen. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Repligen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mettler-Toledo International	$4.09B	5.66	$869.19M	$42.64	26.85
Repligen	$763.34M	9.76	$48.89M	$0.90	146.69

Mettler-Toledo International has a net margin of 21.40% compared to Repligen's net margin of 6.73%. Repligen's return on equity of 4.88% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mettler-Toledo International	21.40%	-622.80%	24.97%
Repligen	6.73%	4.88%	3.48%

Summary

Repligen beats Mettler-Toledo International on 9 of the 17 factors compared between the two stocks.

How does Mettler-Toledo International compare to Bio-Techne?

Mettler-Toledo International (NYSE:MTD) and Bio-Techne (NASDAQ:TECH) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership.

In the previous week, Bio-Techne had 8 more articles in the media than Mettler-Toledo International. MarketBeat recorded 10 mentions for Bio-Techne and 2 mentions for Mettler-Toledo International. Bio-Techne's average media sentiment score of 0.72 beat Mettler-Toledo International's score of 0.00 indicating that Bio-Techne is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mettler-Toledo International	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bio-Techne	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

95.1% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 99.0% of Bio-Techne shares are held by institutional investors. 0.7% of Mettler-Toledo International shares are held by insiders. Comparatively, 1.3% of Bio-Techne shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Mettler-Toledo International has higher revenue and earnings than Bio-Techne. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mettler-Toledo International	$4.09B	5.66	$869.19M	$42.64	26.85
Bio-Techne	$1.22B	7.44	$73.40M	$0.69	83.97

Mettler-Toledo International has a net margin of 21.40% compared to Bio-Techne's net margin of 9.05%. Bio-Techne's return on equity of 13.57% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mettler-Toledo International	21.40%	-622.80%	24.97%
Bio-Techne	9.05%	13.57%	10.66%

Mettler-Toledo International has a beta of 1.27, suggesting that its stock price is 27% more volatile than the broader market. Comparatively, Bio-Techne has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market.

Mettler-Toledo International currently has a consensus target price of $1,408.55, indicating a potential upside of 23.01%. Bio-Techne has a consensus target price of $65.15, indicating a potential upside of 12.45%. Given Mettler-Toledo International's higher probable upside, analysts plainly believe Mettler-Toledo International is more favorable than Bio-Techne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46
Bio-Techne	1 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.67

Summary

Bio-Techne beats Mettler-Toledo International on 11 of the 17 factors compared between the two stocks.

How does Mettler-Toledo International compare to Agilent Technologies?

Mettler-Toledo International (NYSE:MTD) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership and earnings.

Mettler-Toledo International currently has a consensus price target of $1,408.55, indicating a potential upside of 23.01%. Agilent Technologies has a consensus price target of $160.93, indicating a potential upside of 26.23%. Given Agilent Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Agilent Technologies is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46
Agilent Technologies	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.88

Mettler-Toledo International has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market. Comparatively, Agilent Technologies has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market.

In the previous week, Agilent Technologies had 12 more articles in the media than Mettler-Toledo International. MarketBeat recorded 14 mentions for Agilent Technologies and 2 mentions for Mettler-Toledo International. Agilent Technologies' average media sentiment score of 1.15 beat Mettler-Toledo International's score of 0.00 indicating that Agilent Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mettler-Toledo International	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Agilent Technologies	10 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Agilent Technologies has higher revenue and earnings than Mettler-Toledo International. Agilent Technologies is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mettler-Toledo International	$4.09B	5.66	$869.19M	$42.64	26.85
Agilent Technologies	$6.95B	5.18	$1.30B	$4.98	25.60

95.1% of Mettler-Toledo International shares are owned by institutional investors. 0.7% of Mettler-Toledo International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Mettler-Toledo International has a net margin of 21.40% compared to Agilent Technologies' net margin of 19.55%. Agilent Technologies' return on equity of 24.33% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mettler-Toledo International	21.40%	-622.80%	24.97%
Agilent Technologies	19.55%	24.33%	12.99%

Summary

Agilent Technologies beats Mettler-Toledo International on 9 of the 17 factors compared between the two stocks.

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Mettler-Toledo International (NYSE:MTD) and Bio-Rad Laboratories (NYSE:BIO) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, media sentiment, valuation, dividends, risk and profitability.

Mettler-Toledo International has a net margin of 21.40% compared to Bio-Rad Laboratories' net margin of 6.52%. Bio-Rad Laboratories' return on equity of 3.56% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mettler-Toledo International	21.40%	-622.80%	24.97%
Bio-Rad Laboratories	6.52%	3.56%	2.49%

Mettler-Toledo International currently has a consensus target price of $1,408.55, suggesting a potential upside of 23.01%. Bio-Rad Laboratories has a consensus target price of $303.33, suggesting a potential upside of 7.26%. Given Mettler-Toledo International's stronger consensus rating and higher possible upside, equities research analysts plainly believe Mettler-Toledo International is more favorable than Bio-Rad Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mettler-Toledo International	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46
Bio-Rad Laboratories	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mettler-Toledo International	$4.09B	5.66	$869.19M	$42.64	26.85
Bio-Rad Laboratories	$2.59B	2.92	$759.90M	$6.07	46.59

In the previous week, Mettler-Toledo International had 1 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 2 mentions for Mettler-Toledo International and 1 mentions for Bio-Rad Laboratories. Mettler-Toledo International's average media sentiment score of 0.00 equaled Bio-Rad Laboratories'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mettler-Toledo International	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bio-Rad Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Mettler-Toledo International has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, Bio-Rad Laboratories has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market.

95.1% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 65.2% of Bio-Rad Laboratories shares are owned by institutional investors. 0.7% of Mettler-Toledo International shares are owned by insiders. Comparatively, 30.3% of Bio-Rad Laboratories shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Mettler-Toledo International beats Bio-Rad Laboratories on 12 of the 15 factors compared between the two stocks.

Get Mettler-Toledo International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MTD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MTD vs. The Competition

Export

Metric	Mettler-Toledo International	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$23.14B	$6.99B	$6.41B	$23.17B
Dividend Yield	N/A	1.21%	2.67%	4.07%
P/E Ratio	26.85	47.51	24.46	31.57
Price / Sales	5.66	86.64	554.57	103.79
Price / Cash	23.20	25.19	43.94	24.31
Price / Book	-987.13	7.17	10.71	4.68
Net Income	$869.19M	$159.20M	$3.57B	$1.08B
7 Day Performance	0.56%	-0.77%	0.66%	-0.26%
1 Month Performance	6.35%	4.95%	3.66%	2.18%
1 Year Performance	-0.19%	5.63%	28.47%	24.64%

Mettler-Toledo International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MTD Mettler-Toledo International	3.5486 of 5 stars	$1,145.08 +1.4%	$1,408.55 +23.0%	-1.8%	$23.14B	$4.09B	26.85	18,100	News Coverage
BRKR Bruker	2.8305 of 5 stars	$56.63 +4.4%	$51.31 -9.4%	+45.5%	$8.26B	$3.44B	N/A	11,085	Gap Up
RGEN Repligen	3.6773 of 5 stars	$130.87 +0.2%	$164.64 +25.8%	+10.4%	$7.37B	$738.26M	145.41	2,000	Positive News Gap Up
TECH Bio-Techne	3.5156 of 5 stars	$56.17 +4.0%	$65.15 +16.0%	+11.1%	$8.45B	$1.22B	81.41	3,100
A Agilent Technologies	4.9711 of 5 stars	$130.52 +0.5%	$160.93 +23.3%	+7.3%	$36.67B	$6.95B	26.21	18,100	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MTD) was last updated on 6/18/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mettler-Toledo International (MTD) Competitors

MTD vs. BRKR, RGEN, TECH, A, and BIO

How does Mettler-Toledo International compare to Bruker?

Summary

How does Mettler-Toledo International compare to Repligen?

Summary

How does Mettler-Toledo International compare to Bio-Techne?

Summary

How does Mettler-Toledo International compare to Agilent Technologies?

Summary

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTD vs. The Competition

Mettler-Toledo International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mettler-Toledo International (MTD) Competitors

MTD vs. BRKR, RGEN, TECH, A, and BIO

How does Mettler-Toledo International compare to Bruker?

Do analysts prefer BRKR or MTD?

Which has stronger valuation & earnings, BRKR or MTD?

Do insiders and institutionals have more ownership in BRKR or MTD?

Is BRKR or MTD more profitable?

Does the media prefer BRKR or MTD?

Which has more volatility & risk, BRKR or MTD?

Summary

How does Mettler-Toledo International compare to Repligen?

Which has more risk and volatility, MTD or RGEN?

Do analysts rate MTD or RGEN?

Do insiders & institutionals hold more shares of MTD or RGEN?

Does the media favor MTD or RGEN?

Which has stronger earnings and valuation, MTD or RGEN?

Is MTD or RGEN more profitable?

Summary

How does Mettler-Toledo International compare to Bio-Techne?

Does the media refer more to MTD or TECH?

Do institutionals & insiders hold more shares of MTD or TECH?

Which has preferable earnings & valuation, MTD or TECH?

Is MTD or TECH more profitable?

Which has more risk and volatility, MTD or TECH?

Do analysts prefer MTD or TECH?

Summary

How does Mettler-Toledo International compare to Agilent Technologies?

Do analysts rate MTD or A?

Which has more risk and volatility, MTD or A?

Does the media favor MTD or A?

Which has better valuation and earnings, MTD or A?

Do institutionals and insiders believe in MTD or A?

Is MTD or A more profitable?

Summary

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Is MTD or BIO more profitable?

Do analysts recommend MTD or BIO?

Which has preferable earnings and valuation, MTD or BIO?

Does the media refer more to MTD or BIO?

Which has more risk & volatility, MTD or BIO?

Do insiders & institutionals have more ownership in MTD or BIO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTD vs. The Competition

Mettler-Toledo International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools